Pharma Globenewswire

Complicated-Urinary-Tract-Infection-Market-Insights

Complicated Urinary Tract Infection Market Forecast to 2034 Shows Strong Growth, Driven by Antibiotic Innovation and Rising Disease Burden

4 February 2026

The Complicated Urinary Tract Infection (cUTI) market is expected to witness substantial growth through 2034, supported by rising disease prevalence, increasing antimicrobial resistance (AMR), and a robust late-stage antibiotic pipeline, according to DelveInsight’s Complicated Urinary Tract Infection Market Insights, Epidemiology, and Forecast

Market Insights

Clinical Trial Support Services Market Set to Hit USD 43.16B by 2032

4 February 2026

The global clinical trial support services market is set to witness sustained growth, driven by the rising burden of chronic diseases, increasing clinical trial volumes, and expanding pharmaceutical and biotechnology R&D pipelines. According to DelveInsight, the market is projected to reach USD

Market Insights

Invasive Aspergillosis Market Outlook Signals Sustained Growth to 2034

4 February 2026

DelveInsight’s report titled “Invasive Aspergillosis Market Insights, Epidemiology, and Market Forecast – 2034” provides a comprehensive analysis of invasive aspergillosis, covering historical and projected epidemiology trends along with market dynamics across the United States, EU4 (Germany, France, Italy, and Spain), the United

Market Insights

Global Medical Drones Market Poised to Expand at 17.34% CAGR Through 2032, Says DelveInsight

4 February 2026

According to DelveInsight’s assessment, the global medical drones market is set for robust growth, supported by multiple converging factors that are creating a favorable environment for expansion. One of the primary drivers is the rising demand for rapid and reliable delivery of

Autism-Spectrum-Disorder-Pipeline-Insights

Clinical Trials·Market Insights

Autism Spectrum Disorder Pipeline Insight 2025: Emerging Therapies, Clinical Trial Updates, and Regulatory Progress

4 February 2026

The Autism Spectrum Disorder (ASD) Pipeline Insight 2025 highlights a rapidly evolving therapeutic landscape, driven by increasing disease prevalence, advances in neurodevelopmental research, and growing investment in precision medicine. According to DelveInsight, more than 18 biopharmaceutical companies are actively developing 20+ investigational

Clinical Trials

The FDA Grants Fast Track Designation to Novel GPRC5D/CD3 Bispecific Antibody LBL‑034 for Relapsed/Refractory Multiple Myeloma

4 February 2026

The Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to LBL‑034, an investigational GPRC5D/CD3 bispecific T‑cell engager, for the treatment of patients with relapsed or refractory multiple myeloma. The designation is based on encouraging safety, efficacy, and durability signals

Uncategorised

Global Colorectal Surgical Devices Market Expected to Grow at a Steady CAGR of ~8% Through 2032 | DelveInsight

3 February 2026

DelveInsight’s Colorectal Surgical Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Colorectal Surgical Devices Companies market shares, challenges, Colorectal Surgical Devices Market Drivers, barriers, trends, and key market Colorectal Surgical Devices companies in the market. To read more

Uncategorised

PDE4B Inhibitors Market Size Poised for Strong Growth Through 2034, Driven by Innovative Therapies and Clinical Advancements | DelveInsight

3 February 2026

DelveInsight’s “PDE4B Inhibitor Target Population, Competitive Landscape, and Market Forecast – 2034” report delivers an in-depth understanding of the PDE4B inhibitor, historical and projected epidemiological data, competitive landscape as well as the PDE4B inhibitor therapeutics market trends in the United States, EU4

Uncategorised

Myelofibrosis Market Size is projected to grow at a CAGR of 9.00% by 2034, estimates DelveInsight

3 February 2026

DelveInsight’s “Myelofibrosis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Myelofibrosis, historical and forecasted epidemiology and the FSGS market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. Discover

Latest

Complicated Urinary Tract Infection Market Forecast to 2034 Shows Strong Growth, Driven by Antibiotic Innovation and Rising Disease Burden

Clinical Trial Support Services Market Set to Hit USD 43.16B by 2032

Invasive Aspergillosis Market Outlook Signals Sustained Growth to 2034

Global Medical Drones Market Poised to Expand at 17.34% CAGR Through 2032, Says DelveInsight

Autism Spectrum Disorder Pipeline Insight 2025: Emerging Therapies, Clinical Trial Updates, and Regulatory Progress

The FDA Grants Fast Track Designation to Novel GPRC5D/CD3 Bispecific Antibody LBL‑034 for Relapsed/Refractory Multiple Myeloma

Global Colorectal Surgical Devices Market Expected to Grow at a Steady CAGR of ~8% Through 2032 | DelveInsight

PDE4B Inhibitors Market Size Poised for Strong Growth Through 2034, Driven by Innovative Therapies and Clinical Advancements | DelveInsight

Myelofibrosis Market Size is projected to grow at a CAGR of 9.00% by 2034, estimates DelveInsight

Recent Posts

Banner

Newsletter

Authors